Axon Lab SA
13.3 FTEAxon Lab reported total assets of €3.28m at the end of the 2025 financial year (annual accounts filed with the NBB on 19 May 2026), with 13.3 full-time equivalents.
The score of Axon Lab shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +11 % Total assets +248 % Headcount (avg FTE) +209 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Axon Lab's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 19 May 2026
- Year ended 31 Dec 2024filed on 06 Jun 2025
- Year ended 31 Dec 2023filed on 15 May 2024
- Year ended 31 Dec 2022filed on 12 May 2023
- Year ended 31 Dec 2021filed on 13 May 2022
Axon Lab's financial analysis
- Solvency21.2%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Axon Lab
Axon Lab's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0546.789.493
- VAT number
- BE0546789493
- Peppol
- Registered · 0208:0546789493 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 21 Feb 2014
- Registered office
- 1831 Machelen (Brab.)
- Size
- Small · 13.3 FTE
- Latest accounts
- 2025 · filed on 19 May 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Axon Lab (SA) has been based in Machelen (Brab.) since 2014, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 5,086 € and equity of 694,802 €; its revenue is not published. With 13.3 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 21.2%, below the median of its sector (46.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Axon Lab
Companies in the same business, of comparable size and area, outside its group.
- Biocon Biologics Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €1.09m
- Guerbet Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €3.45m
- Tromp Medical Wholesale of pharmaceutical and medical goods Zaventem · balance sheet €2.64m
- Michiels Wholesale of pharmaceutical and medical goods Brussels · balance sheet €5.00m
- Endoceutics Wholesale of pharmaceutical and medical goods Brussels · balance sheet €3.45m
- Launchpad Europe Wholesale of pharmaceutical and medical goods Oostkamp · balance sheet 120,635 €
- Maimonides Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 142 €
- Wimeq Wholesale of pharmaceutical and medical goods Heusden-Zolder · balance sheet 48,978 €
Frequently asked questions about Axon Lab
What is the revenue of Axon Lab?
Axon Lab files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Axon Lab?
In Belgium, the VAT number is the company number prefixed with BE: BE0546789493 for Axon Lab, if the company is VAT-registered. Its company number (CBE) is 0546.789.493.
Where is the registered office of Axon Lab?
According to the CBE register, the registered office of Axon Lab is in 1831 Machelen (Brab.).
What is the equity of Axon Lab?
At the close of the 2025 financial year, the equity of Axon Lab amounts to 694,802 €, a solvency of 21.2% of total assets.
How many people work at Axon Lab?
13.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Axon Lab?
The register lists 3 active mandates at Axon Lab. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Axon Lab
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →